78 related articles for article (PubMed ID: 9524061)
1. Thyropins--new structurally related proteinase inhibitors.
Lenarcic B; Bevec T
Biol Chem; 1998 Feb; 379(2):105-11. PubMed ID: 9524061
[TBL] [Abstract][Full Text] [Related]
2. Two decades of thyroglobulin type-1 domain research.
Mihelic M; Turk D
Biol Chem; 2007 Nov; 388(11):1123-30. PubMed ID: 17976004
[TBL] [Abstract][Full Text] [Related]
3. Diversity and evolution of the thyroglobulin type-1 domain superfamily.
Novinec M; Kordis D; Turk V; Lenarcic B
Mol Biol Evol; 2006 Apr; 23(4):744-55. PubMed ID: 16368776
[TBL] [Abstract][Full Text] [Related]
4. Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain.
Lenarcic B; Ritonja A; Strukelj B; Turk B; Turk V
J Biol Chem; 1997 May; 272(21):13899-903. PubMed ID: 9153250
[TBL] [Abstract][Full Text] [Related]
5. Individual recombinant thyroglobulin type-1 domains are substrates for lysosomal cysteine proteinases.
Pungercic G; Dolenc I; Dolinar M; Bevec T; Jenko S; Kolaric S; Turk V
Biol Chem; 2002 Nov; 383(11):1809-12. PubMed ID: 12530546
[TBL] [Abstract][Full Text] [Related]
6. Invariant chain transmembrane domain trimerization: a step in MHC class II assembly.
Dixon AM; Stanley BJ; Matthews EE; Dawson JP; Engelman DM
Biochemistry; 2006 Apr; 45(16):5228-34. PubMed ID: 16618111
[TBL] [Abstract][Full Text] [Related]
7. Structural studies of cysteine proteases and their inhibitors.
Grzonka Z; Jankowska E; Kasprzykowski F; Kasprzykowska R; Lankiewicz L; Wiczk W; Wieczerzak E; Ciarkowski J; Drabik P; Janowski R; Kozak M; Jaskólski M; Grubb A
Acta Biochim Pol; 2001; 48(1):1-20. PubMed ID: 11440158
[TBL] [Abstract][Full Text] [Related]
8. Carboxy terminal extended phytocystatins are bifunctional inhibitors of papain and legumain cysteine proteinases.
Martinez M; Diaz-Mendoza M; Carrillo L; Diaz I
FEBS Lett; 2007 Jun; 581(16):2914-8. PubMed ID: 17543305
[TBL] [Abstract][Full Text] [Related]
9. Pro domain peptide of HGCP-Iv cysteine proteinase inhibits nematode cysteine proteinases.
Silva FB; Batista JA; Marra BM; Fragoso RR; Monteiro AC; Figueira EL; Grossi-de-Sá MF
Genet Mol Res; 2004 Sep; 3(3):342-55. PubMed ID: 15614726
[TBL] [Abstract][Full Text] [Related]
10. Cystatins may confer viral resistance in plants by inhibition of a virus-induced cell death phenomenon in which cysteine proteinases are active: cloning and molecular characterization of a cDNA encoding cysteine-proteinase inhibitor (celostatin) from Celosia cristata (crested cock's comb).
Gholizadeh A; Santha IM; Kohnehrouz BB; Lodha ML; Kapoor HC
Biotechnol Appl Biochem; 2005 Dec; 42(Pt 3):197-204. PubMed ID: 15842197
[TBL] [Abstract][Full Text] [Related]
11. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
Hariharan R; Pillai MR
Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
[TBL] [Abstract][Full Text] [Related]
12. Comparison of chemical characteristics of three soybean cysteine proteinase inhibitors.
Lalitha S; Shade RE; Murdock LM; Hasegawa PM; Bressan RA; Nielsen SS
J Agric Food Chem; 2005 Mar; 53(5):1591-7. PubMed ID: 15740045
[TBL] [Abstract][Full Text] [Related]
13. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
Pol E; Björk I
Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
[TBL] [Abstract][Full Text] [Related]
14. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
Schirmeister T
J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family.
Kyrieleis OJ; Huber R; Ong E; Oehler R; Hunter M; Madison EL; Jacob U
FEBS J; 2007 Apr; 274(8):2148-60. PubMed ID: 17388811
[TBL] [Abstract][Full Text] [Related]
16. Sea bass (Dicentrarchus labrax) invariant chain and class II major histocompatibility complex: sequencing and structural analysis using 3D homology modelling.
Silva DS; Reis MI; Nascimento DS; do Vale A; Pereira PJ; dos Santos NM
Mol Immunol; 2007 Jul; 44(15):3758-76. PubMed ID: 17512596
[TBL] [Abstract][Full Text] [Related]
17. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.
Manoury B; Hewitt EW; Morrice N; Dando PM; Barrett AJ; Watts C
Nature; 1998 Dec; 396(6712):695-9. PubMed ID: 9872320
[TBL] [Abstract][Full Text] [Related]
18. Compensatory proteolytic responses to dietary proteinase inhibitors in the red flour beetle, Tribolium castaneum (Coleoptera: Tenebrionidae).
Oppert B; Morgan TD; Hartzer K; Kramer KJ
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Jan; 140(1):53-8. PubMed ID: 15792623
[TBL] [Abstract][Full Text] [Related]
19. Equistatin, a protease inhibitor from the sea anemone actinia equina, is composed of three structural and functional domains.
Strukelj B; Lenarcic B; Gruden K; Pungercar J; Rogelj B; Turk V; Bosch D; Jongsma MA
Biochem Biophys Res Commun; 2000 Mar; 269(3):732-6. PubMed ID: 10720485
[TBL] [Abstract][Full Text] [Related]
20. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.
López D; Del Val M
J Immunol; 1997 Dec; 159(12):5769-72. PubMed ID: 9550370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
